CliniSciences ApS Financials, key figures and credit report
Gross profit 846.0 kDKK FY 2025 +9% vs 2024
EBIT -20.2 kDKK FY 2025 +84.9% vs 2024
Net debt 1 527.8 kDKK FY 2025 +810.9% vs 2024
Quick ratio 1.3 FY 2025 +0.4 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 385.91 | 549.73 | 586.09 | 776.33 | 846.02 |
| Employee benefit expenses | -81.93 | - 721.35 | - 817.91 | - 739.01 | - 694.78 |
| Total depreciation | -56.19 | - 171.43 | - 171.43 | - 171.43 | - 171.43 |
| EBIT | 247.79 | - 343.05 | - 403.24 | - 134.12 | -20.19 |
| Other financial income | 0.34 | 4.44 | 4.84 | 7.26 | 10.71 |
| Other financial expenses | -2.71 | -15.02 | - 105.51 | - 117.40 | -60.24 |
| Pre-tax profit | 245.42 | - 353.64 | - 503.91 | - 244.26 | -69.73 |
| Income taxes | -55.41 | 77.55 | 111.10 | 53.70 | 15.33 |
| Net earnings | 190.01 | - 276.09 | - 392.81 | - 190.55 | -54.40 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Goodwill | 1 143.81 | 972.38 | 800.95 | 629.51 | 458.08 |
| Intangible assets total | 1 143.81 | 972.38 | 800.95 | 629.51 | 458.08 |
| Tangible assets total | |||||
| Investments total | |||||
| Deferred tax assets | 77.55 | 188.14 | 241.58 | 256.92 | |
| Long term receivables total | 77.55 | 188.14 | 241.58 | 256.92 | |
| Inventories total | |||||
| Current trade debtors | 313.55 | 430.26 | 237.10 | 301.69 | 394.69 |
| Current amounts owed by group member comp. | 12.24 | ||||
| Prepayments and accrued income | 1.50 | 3.54 | 2.96 | ||
| Current other receivables | 7.50 | 20.00 | 20.00 | 15.00 | 24.25 |
| Current deferred tax assets | 14.50 | 6.56 | 4.11 | ||
| Short term receivables total | 321.05 | 450.26 | 273.10 | 339.04 | 426.02 |
| Cash and bank deposits | 370.44 | 65.79 | 917.49 | 1 635.85 | 1 638.18 |
| Cash and cash equivalents | 370.44 | 65.79 | 917.49 | 1 635.85 | 1 638.18 |
| Balance sheet total (assets) | 1 835.30 | 1 565.98 | 2 179.68 | 2 845.98 | 2 779.20 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | 190.01 | -86.08 | - 478.89 | - 669.45 | |
| Profit of the financial year | 190.01 | - 276.09 | - 392.81 | - 190.55 | -54.40 |
| Shareholders equity total | 230.01 | -46.08 | - 438.89 | - 629.45 | - 683.84 |
| Provisions | 25.35 | 26.45 | 25.91 | 25.89 | 96.37 |
| Non-current owed to group member | 1 317.62 | 1 420.94 | 1 820.20 | ||
| Non-current liabilities total | 1 317.62 | 1 420.94 | 1 820.20 | ||
| Current trade creditors | 271.26 | 262.42 | 1 031.50 | 1 809.50 | 10.16 |
| Current owed to group member | 1 222.02 | 1 220.00 | 1 345.78 | ||
| Short-term deferred tax liabilities | 30.06 | ||||
| Other non-interest bearing current liabilities | 56.59 | 103.19 | 243.55 | 219.10 | 190.53 |
| Current liabilities total | 1 579.94 | 1 585.61 | 1 275.05 | 2 028.61 | 1 546.47 |
| Balance sheet total (liabilities) | 1 835.30 | 1 565.98 | 2 179.68 | 2 845.98 | 2 779.20 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated